Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Return on Investment of the COVID-19 Vaccination Campaign in New York City

Title: Return on Investment of the COVID-19 Vaccination Campaign in New York City
Authors: Sah, Pratha; Vilches, Thomas N.; Moghadas, Seyed M.; Pandey, Abhishek; Gondi, Suhas; Schneider, Eric C.; Singer, Jesse; Chokshi, Dave A.; Galvani, Alison P.
Source: JAMA Network Open ; volume 5, issue 11, page e2243127 ; ISSN 2574-3805
Publisher Information: American Medical Association (AMA)
Publication Year: 2022
Description: Importance New York City, an early epicenter of the pandemic, invested heavily in its COVID-19 vaccination campaign to mitigate the burden of disease outbreaks. Understanding the return on investment (ROI) of this campaign would provide insights into vaccination programs to curb future COVID-19 outbreaks. Objective To estimate the ROI of the New York City COVID-19 vaccination campaign by estimating the tangible direct and indirect costs from a societal perspective. Design, Setting, and Participants This decision analytical model of disease transmission was calibrated to confirmed and probable cases of COVID-19 in New York City between December 14, 2020, and January 31, 2022. This simulation model was validated with observed patterns of reported hospitalizations and deaths during the same period. Exposures An agent-based counterfactual scenario without vaccination was simulated using the calibrated model. Main Outcomes and Measures Costs of health care and deaths were estimated in the actual pandemic trajectory with vaccination and in the counterfactual scenario without vaccination. The savings achieved by vaccination, which were associated with fewer outpatient visits, emergency department visits, emergency medical services, hospitalizations, and intensive care unit admissions, were also estimated. The value of a statistical life (VSL) lost due to COVID-19 death and the productivity loss from illness were accounted for in calculating the ROI. Results During the study period, the vaccination campaign averted an estimated $27.96 (95% credible interval [CrI], $26.19-$29.84) billion in health care expenditures and 315 724 (95% CrI, 292 143-340 420) potential years of life lost, averting VSL loss of $26.27 (95% CrI, $24.39-$28.21) billion. The estimated net savings attributable to vaccination were $51.77 (95% CrI, $48.50-$55.85) billion. Every $1 invested in vaccination yielded estimated savings of $10.19 (95% CrI, $9.39-$10.87) in direct and indirect costs of health outcomes that would have been incurred without ...
Document Type: article in journal/newspaper
Language: English
DOI: 10.1001/jamanetworkopen.2022.43127
Availability: https://doi.org/10.1001/jamanetworkopen.2022.43127; https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2798827/sah_2022_oi_221213_1668176862.76735.pdf
Accession Number: edsbas.91135D29
Database: BASE